Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who have been diagnosed with breast cancer or colorectal cancer, or adults who have no cancer (referred to as healthy controls)
- People who are able to have a blood draw after fasting (going without food for a period of time before the test)
- Pregnant women are also welcome to take part, as the study procedures are not considered a risk to the woman or the unborn child
Who may not be able to join:
- People who are unable or unwilling to give their informed consent to participate
- People who are under 18 years of age
- People who are currently incarcerated (in prison or jail)
- People who lack the capacity to consent for themselves
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Deborah Altomare, PhD, University of Central Florida College of Medicine
Phone: 407-266-8742
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To Identify and test thresholds, specificity and sensitivity for FGF19, (and associated markers) for detection in human blood of breast and colorectal in cancer patients, and see if occurs at higher rates than healthy controls.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.